
Sustainable Future Goals
Karger Publishers supports and endorses the United Nations Sustainable Development Goals.
The United Nations Sustainable Development Goals (UN SDGs) are a roadmap and a call to action for everybody to transform the world by 2030. We endorse the UN SDGs and particularly focus on two of the seventeen SDGs.
We have also signed the UN SDG Publishers Compact and are committed to achieving its ten goals. The Publishers Compact was launched at the Frankfurt Book Fair 2020. It is a pledge consisting of ten steps to which publishers can commit in order to help achieve the SDGs by 2030.
EcoVadis provides companies with holistic corporate social responsibility (CSR) ratings. The EcoVadis rating covers a wide range of non-financial management systems, including environmental impact, labor and human rights, ethics and sustainable procurement. Each company is assessed on the issues that are relevant to its size, location and industry. Karger Publishers has been awarded a bronze medal in recognition of its sustainability achievement. View the Karger EcoVadis Scorecard
#3 Good Health and Well-Being
We aim to connect and advance health sciences and our products and services cater to the information needs of the health sciences community. The content we deliver advances scientific discoveries that help to improve health and well-being.
As easy access to scientific knowledge is more important than ever to support research, especially in these times, we are continuing to drive forward the transition to Open Access (OA). After launching our first OA journal in 2007, the volume of OA journals and articles has grown continuously, and we aim to continue pursuing this strategy in the future. We have also made access to our Fast Facts medical handbook series free for registered users.
We consider it our duty to support the fight against the coronavirus. This is why we have been enabling free access to our research articles on COVID-19 since February 2020. In addition, the first issue of our new journal Kompass Nutrition & Dietetics explores how nutritional and behavioral measures may mitigate the risk of a severe course of coronavirus infection.
We have also taken measures to ensure the continued health and safety of our colleagues, customers, and partners in this unprecedented situation, as outlined by the Chairwoman of our Board of Directors, Gabriella Karger.
Within SDG 3, our content specifically focuses on the following Targets
Target 3.1:
By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births.Selected Articles
-
Opportunities and Challenges in Global Perinatal Research
Duby J. · Sharma R. · Bhutta Z.A.
Neonatology 2018;114:93-102 (DOI:10.1159/000488310) -
Challenges in Managing Pregnancy in Underserved Women with Chronic Kidney Disease
Ibarra-Hernandez M. · Alcantar-Vallin M.L. · Soto-Cruz A. · Jimenez-Alvarado P.M. · Villa-Villagran F. · Diaz-Avila J.J. · Tamez-Hernandez F. · Leon-Barrios M. · Chatrenet A. · Piccoli G.B. · Garcia-Garcia G.
Am J Nephrol 2019;49:386-396 (DOI:10.1159/000499964) -
COVID-19 (SARS-CoV-2) Infection in Pregnancy: A Systematic Review
Akhtar H. · Patel C. · Abuelgasim E. · Harky A.
Gynecol Obstet Invest 2020;85:295-306 (DOI:10.1159/000509290) -
Perinatal Iron Deficiency: Implications for Mothers and Infants
Juul S.E. · Derman R.J. · Auerbach M.
Neonatology 2019;115:269-274 (DOI:10.1159/000495978) -
Pregnancy-Related Acute Kidney Injury in the United States: Clinical Outcomes and Health Care Utilization
Shah S. · Meganathan K. · Christianson A.L. · Harrison K. · Leonard A.C. · Thakar C.V.
Am J Nephrol 2020;51:216-226 (DOI:10.1159/000505894)
Target 3.2:
By 2030, end preventable deaths of newborns and children under five years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-five mortality to at least as low as 25 per 1,000 live births.
Selected Articles
-
Factors Associated with Survival and Survival without Major Morbidity in Very Preterm Infants in Two Neonatal Networks: SEN1500 and NEOCOSUR
García-Muñoz Rodrigo F. · Fabres J. · Tapia J.L. · D’Apremont I.D. · San Feliciano L. · Zozaya Nieto C. · Figueras-Aloy J. · Mariani G. · Musante G. · Silvera F. · Zegarra J. · Vento M.
Neonatology 2021;118:289-296 (DOI:10.1159/000513079) -
Early PARacetamol (EPAR) Trial: A Randomized Controlled Trial of Early Paracetamol to Promote Closure of the Ductus Arteriosus in Preterm Infants
Schindler T. · Smyth J. · Bolisetty S. · Michalowski J. · Mallitt K.-A. · Singla A. · Lui K.
Neonatology 2021;118:274-281 (DOI:10.1159/000515415) -
Optimal Ventilation and Surfactant Therapy in Very-Low-Birth-Weight Infants in Resource-Restricted Regions
Van Wyk L. · Tooke L. · Dippenaar R. · Rhoda N. · Lloyd L. · Holgate S. · Alexander R. · Smith J.
Neonatology 2020;117:217-224 (DOI:10.1159/000506987) -
Nasal High-Frequency Oscillatory Ventilation in Preterm Infants with Moderate Respiratory Distress Syndrome: A Multicenter Randomized Clinical Trial
Zhu X. · Feng Z. · Liu C. · Shi L. · Shi Y. · Ramanathan R. · on behalf of the NHFOV study group
Neonatology 2021;118:325-331 (DOI:10.1159/000515226)
Target 3.3:
By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases, and other communicable disease.
Selected Articles
-
Defining Outcomes of Tuberculosis (Treatment): From the Past to the Future
Günther G. · Heyckendorf J. · Zellweger J.P. · Reimann M. · Claassens M. · Chesov D. · van Leth F.
Respiration 2016;85:158-180 (DOI:10.1159/000516392) -
Neurovascular Interactions in Malaria
Lima M.N. · Freitas R.J.R.X. · Passos B.A.B.R. · Darze A.M.G. · Castro-Faria-Neto H.C. · Maron-Gutierrez T.
Neuroimmunomodulation 2021;28:108-117 (DOI:10.1159/000515557) -
Efferocytosis of Apoptotic Neutrophils Enhances Control of Mycobacterium tuberculosis in HIV-Coinfected Macrophages in a Myeloperoxidase-Dependent Manner
Andersson A.-M. · Larsson M. · Stendahl O. · Blomgran R.
J Innate Immun 2020;12:235-247 (DOI:10.1159/000500861) -
The Route of Infection Influences the Contribution of Key Immunity Genes to Antibacterial Defense in Anopheles gambiae
Dekmak A.S. · Yang X. · Zu Dohna H. · Buchon N. · Osta M.A.
J Innate Immun 2021;13:107-126 (DOI:10.1159/000511401) -
Primary Human Neutrophils Exhibit a Unique HIV-Directed Antibody-Dependent Phagocytosis Profile
Powell R.L.R. · Fox A. · Itri V. · Zolla-Pazner S.
J Innate Immun 2019;11:181-190 (DOI:10.1159/000494371) -
SERINC5 Is an Unconventional HIV Restriction Factor That Is Upregulated during Myeloid Cell Differentiation
Zutz A. · Schölz C. · Schneider S. · Pierini V. · Münchhoff M. · Sutter K. · Wittmann G. · Dittmer U. · Draenert R. · Bogner J.R. · Fackler O.T. · Keppler O.T.
J Innate Immun 2020;12:399-409 (DOI:10.1159/000504888) -
Disease Burden, Risk Factors, and Recent Trends of Liver Cancer: A Global Country-Level Analysis
Huang J. · Lok V. · Ngai C.H. · Chu C. · Patel H.K. · Thoguluva Chandraseka V. · Zhang L. · Chen P. · Wang S. · Lao X.-Q. · Tse L.A. · Xu W. · Zheng Z.-J. · Wong M.C.S.
Liver Cancer 2021;10:330-345 (DOI:10.1159/000515304)
Target 3.4:
By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being.
- Cardiovascular System
- Gastroenterology
- Genetics
- Hematology
- Nephrology
- Nutrition and Dietetics
- Neurology and Neuroscience
- Oncology
- Public Health
Selected Articles
-
The Epidemiology of Epilepsy
Beghi E.
Neuroepidemiology 2020;54:185-191 (DOI:10.1159/000503831) -
Global, Regional and Country-Specific Burden of Ischaemic Stroke, Intracerebral Haemorrhage and Subarachnoid Haemorrhage: A Systematic Analysis of the Global Burden of Disease Study 2017
Krishnamurthi R.V. · Ikeda T. · Feigin V.L.
Neuroepidemiology 2020;54:171-179 (DOI:10.1159/000506396) -
Nutrition in Inflammatory Bowel Disease
Schreiner P. · Martinho-Grueber M. · Studerus D. · Vavricka S.R. · Tilg H. · Biedermann L. · on behalf of Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology
Digestion 2020;101(suppl 1):120-135 (DOI:10.1159/000505368) -
Gut Microbiota: A Perspective for Psychiatrists
Rea K. · Dinan T.G. · Cryan J.F.
Neuropsychobiology 2020;79:50-62 (DOI:10.1159/000504495) -
Update on Lupus Nephritis: Looking for a New Vision
Morales E. · Galindo M. · Trujillo H. · Praga M.
Nephron 2021;145:1-13 (DOI:10.1159/000511268) -
A Personalized Update on IgA Nephropathy: A New Vision and New Future Challenges
Gutiérrez E. · Carvaca-Fontán F. · Luzardo L. · Morales E. · Alonso M. · Praga M.
Nephron 2020;144:555-571 (DOI:10.1159/000509997) -
Availability and Affordability of Kidney Health Laboratory Tests around the Globe
Tummalapalli S.L. · Shlipak M.G. · Damster S. · Jha V. · Malik C. · Levin A. · Johnson D.W. · Bello A.K.
Am J Nephrol 2020;51:959-965 (DOI:10.1159/000511848) -
Heat Stress Impacts on Cardiac Mortality in Nepali Migrant Workers in Qatar
Pradhan B. · Kjellstrom T. · Atar D. · Sharma P. · Kayastha B. · Bhandari G. · Pradhan P.K.
Cardiology 2019;143:37-48 (DOI:10.1159/000500853) -
St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer
Thomssen C. · Balic M. · Harbeck N. · Gnant M.
Breast Care 2021;16:135-143 (DOI:10.1159/000/516114) -
The European Association for the Study of Obesity (EASO) Endorses the Milan Charter on Urban Obesity
Carruba M.O. · Busetto L. · Bryant S. · Caretto A. · Farpour-Lambert N.J. · Fatati G. · Foschi D. · Giorgino F. · Halford J.C.G. · Lenzi A. · Malfi G. · O'Malley G. · Napier D. · Santini F. · Sbraccia P. · Spinato C. · Woodward E. · Nisoli E.
Obes Facts 2021;14:163-168 (DOI:10.1159/000514218) -
Total Dietary Fat Intake, Fat Quality, and Health Outcomes: A Scoping Review of Systematic Reviews of Prospective Studies
Schwingshackl L. · Zähringer J. · Beyerbach J. · Werner S.W. · Heseker H. · Koletzko B. · Meerpohl J.J.
Ann Nutr Metab 2021;77:4-15 (DOI:10.1159/000515058) -
Heavy Drinking Habits Are Associated with Worse In-Hospital Outcomes in Patients with Acute Coronary Syndrome: An Insight from the AMIS Plus Registry
Tersalvi G. · Biasco L. · Radovanovic D. · Rickli H. · Roffi M. · Eberli F. · Moccetti M. · Jeger R. · Moccetti T. · Erne P. · Pedrazzini G.
Cardiology 2020;145:757-765 (DOI:10.1159/000508928)
Target 3.5:
Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol.
Selected Articles
-
Effect of Assertive Community Treatment for Patients with Substance Use Disorder: A Systematic Review
Penzenstadler L. · Soares C. · Anci E. · Molodynski A. · Khazaal Y.
Eur Addict Res 2019;25:56-67 (DOI:10.1159/000496742) -
How Are Self-Efficacy and Motivation Related to Drinking Five Years after Residential Treatment A Longitudinal Multicenter Study
Müller A. · Znoj H. · Moggi F.
Eur Addict Res 2019;25:213-223 (DOI:10.1159/000500520) -
Substance Use and Prevention Programs in Berlin’s Party Scene: Results of the SuPrA-Study
Betzler F. · Ernst F. · Helbig J. · Viohl L. · Roediger L. · Meister S. · Romanczuk-Seiferth N. · Heinz A. · Ströhle A. · Köhler S.
Eur Addict Res 2019;25:283-292 (DOI:10.1159/000501310) -
International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder
Özgen H. · Spijkerman R. · Noack M. · Holtmann M. · Schellekens A.S.A. · van de Glind G. · Banaschewski T. · Barta C. · Begeman A. · Casas M. · Crunelle C.L. · Daigre Blanco C. · Dalsgaard S. · Demetrovics Z. · den Boer J. · Dom G. · Eapen V. · Faraone S.V. · Franck J. · González R.A. · Grau-López L. · Groenman A.P. · Hemphälä M. · Icick R. · Johnson B. · Kaess M. · Kapitány-Fövény M. · Kasinathan J.G. · Kaye S.S. · Kiefer F. · Konstenius M. · Levin F.R. · Luderer M. · Martinotti G. · Matthys F.I.A. · Meszaros G. · Moggi F. · Munasur-Naidoo A.P. · Post M. · Rabinovitz S. · Ramos-Quiroga J.A. · Sala R. · Shafi A. · Slobodin O. · Staal W.G. · Thomasius R. · Truter I. · van Kernebeek M.W. · Velez-Pastrana M.C. · Vollstädt-Klein S. · Vorspan F. · Young J.T. · Yule A. · van den Brink W. · Hendriks V.
Eur Addict Res 2020;26:223-232 (DOI:10.1159/000508385) -
Alcohol Use and Cancer in the European Union
Rehm J. · Shield K.D.
Eur Addict Res 2021;27:1-8 (DOI:10.1159/000507017) -
The Role of Psychological Distress in the Relationship between Drinking Motives and Hazardous Drinking in Older Adults
van Gils Y. · Franck E. · Dierckx E. · van Alphen S.P.J. · Dom G.
Eur Addict Res 2021;27:33-41 (DOI:10.1159/000507664) -
Fewer Cancer Cases in 4 Countries of the WHO European Region in 2018 through Increased Alcohol Excise Taxation: A Modelling Study
Rovira P. · Kilian C. · Neufeld M. · Rumgay H. · Soerjomataram I. · Ferreira-Borges C. · Shield K.D. · Sornpaisarn B. · Rehm J.
Eur Addict Res 2021;27:189-197 (DOI:10.1159/000511899) -
Comparison of European Clinical Guidelines on the Management of Alcohol Use Disorders
Drummond C. · Hillyard M. · Leonhardt M. · Wurst F. · Dom G. · Mann K. · Bramness J.G.
Eur Addict Res 2021;27:227-235 (DOI:10.1159/000512112) -
When the Burden Gets Overwhelming: Testing an Inverse U-Shaped Relation between Work-Family Conflicts and Alcohol Use
Kuntsche S. · Kuntsche E.
Eur Addict Res 2021;27:42-48 (DOI:10.1159/000507665) -
Explaining the Differences in Opioid Overdose Deaths between Scotland and England/Wales: Implications for European Opioid Policies
van Amsterdam J. · van den Brink W. · Pierce M.
Eur Addict Res (DOI:10.1159/000516165)
#7 Affordable and Clean Energy
We place great value on the use of sustainable energy and other resources.
Within SDG 7, we specifically focus on the following Targets
Target 7.2:
By 2030, increase substantially the share of renewable energy in the global energy mix.
Renewable Energy
The energy we consume is produced through certified regional hydropower, and we make use of waste heat from a local refuse incineration plant in Basel. Similarly, the water we use is sourced locally at Hardwald and Lange Erlen.
Target 7.3:
By 2030, double the global rate of improvement in energy efficiency.
Energy Efficiency
In 2008 and 2009, the insulation of the building at our headquarters was modernized to save energy.
This diagram shows the heat consumption of headquarter building at Allschwilerstrasse 10 in Basel. The heat consumption dropped after the modernization of the insulation of the building. Other variations are due to different winter temperatures over the years.
We use paper with an ecolabel from the Forest Stewardship Council (FSC) for our packaging material. Our publications are available digitally, and the small number of print copies has decreased continuously over the years. This also reduces the amount of energy used for shipping.
We raise awareness among our employees to promote the conscious use energy and other resources.
Testimonial
“Sustainability efforts, whether small or large, on an economic, social, and ecological level, are extremely important for Karger Publishers. Even as a medium-sized business, we would like to play our part. The SDG #3 Good Health and Well-Being is in line with our strategy, which aims to serve the information needs of our stakeholders in the ‘Cycle of Knowledge in Health Sciences’.”
Gabriella Karger, Publisher & Chairwoman of the Board of Directors
Contact
If you have any questions, please do not hesitate to contact us